دورية أكاديمية

ASO Author Reflections: High-Intensity Focused Ultrasound will Become the Routine Practice for Treatment of Localized Prostate Cancer.

التفاصيل البيبلوغرافية
العنوان: ASO Author Reflections: High-Intensity Focused Ultrasound will Become the Routine Practice for Treatment of Localized Prostate Cancer.
المؤلفون: Tsai MY; Department of Urology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Lin CT; Department of International Education, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Chiang PH; Department of International Education, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Chiang PH; Department of Urology, Jhong Siao Urological Hospital, Kaohsiung, Taiwan., Chiang PC; Department of Urology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. pingagaga@hotmail.com.
المصدر: Annals of surgical oncology [Ann Surg Oncol] 2023 Dec; Vol. 30 (13), pp. 8786-8787. Date of Electronic Publication: 2023 Sep 25.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2005- : New York, NY : Springer
Original Publication: New York, NY : Raven Press, c1994-
مواضيع طبية MeSH: Ultrasound, High-Intensity Focused, Transrectal* , Prostatic Neoplasms*/surgery, Male ; Humans ; Treatment Outcome ; Prostate ; Prostatectomy
مستخلص: PAST: Most prostate cancers are slow growing and are often diagnosed at an old age, which may result in treatment never being needed. However, definitive treatments such as radical prostatectomy and radiation therapy are often associated with many serious adverse effects, harming the physical and mental health of patients. PRESENT: In recent years, different types of minimally invasive therapy have been developed to achieve cancer control, continence, and even potency preservation, such as high-intensity focused ultrasound (HIFU). HIFU has been proposed for prostate cancer patients to provide an equivalent oncologic result to definitive treatment, with a reduced adverse effect profile, thus increasing the interest in HIFU for the treatment of localized prostate cancer. FUTURE: Sonablate ® HIFU performed an outstanding cancer control in treating localized prostate cancer, with low biochemical recurrence and complication rates. As further long-term follow-up data mature, we anticipate the routine application of HIFU for localized prostate cancer within the next few years.
(© 2023. Society of Surgical Oncology.)
References: Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. (PMID: 10.3322/caac.2149230207593)
Eastham JA, PT Scardino, MW Kattan. Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol. 2008;179(6):2207–10; discussion 2210-1.
Valerio M, et al. The role of focal therapy in managing localized prostate cancer: a systematic review. Eur Urol. 2014;66(4):732–51. (PMID: 10.1016/j.eururo.2013.05.048237698254179888)
Lin CT, Chiang PH, Tsai MY, Chiang PH, Chiang PC. High-Intensity focused ultrasound (Sonablate ® ) for prostate cancer: preliminary outcomes in Taiwan. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14250-4 . (PMID: 10.1245/s10434-023-14250-43784366810495485)
Mearini L, Porena M. Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future. Indian J Urol. 2010;26(1):4–11. https://doi.org/10.4103/0970-1591.60436 . (PMID: 10.4103/0970-1591.60436205352782878418)
Huang YC, Kan CH, Chiang PH, et al. Salvage radiotherapy plus androgen deprivation therapy for high-risk prostate cancer with biochemical failure after high-intensity focused ultrasound as primary treatment. J Clin Med. 2022;11:4450–8. (PMID: 10.3390/jcm11154450359560699369757)
تواريخ الأحداث: Date Created: 20230925 Date Completed: 20231108 Latest Revision: 20231108
رمز التحديث: 20231215
DOI: 10.1245/s10434-023-14297-3
PMID: 37749406
قاعدة البيانات: MEDLINE
الوصف
تدمد:1534-4681
DOI:10.1245/s10434-023-14297-3